In reality, the association of telomere length to longevity is modest, and is linked to non-cancer causes of death, and lifestyle choices like smoking, stress, and obesity heavily influence telomere lengthso we dont know if alternative telomere manipulations from a peptide would help at all
However, the TRIUMPH-1 Phase 3 trial results indicated significant weight loss, with participants losing up to 28.3% of their body weight at 80 weeks
2024;doi:10.1016/S0140-6736(24)01763-X
The gradual dose titration recommended by prescribers is specifically designed to minimise these effects
Storage : Store lyophilized powder at 28C in a dark, dry environment
Todays newsletter, with obesity expert and lecturer in physiology at Anglia Ruskin university Dr Simon Cork, is about what weve just learned, why it changes our understanding of semaglutides and whether it will mean they become more widely available